                               SEQUENCE LISTING

<110> XU, JIAN QING 
      ZHANG, XIAO YAN 
      WANG, JING 
      ZHU, LING YAN
      LUBIT, BEVERLY W. 

<120> UNIVERSAL VACCINES AGAINST IMMUNOGENS OF PATHOGENIC ORGANISMS 
      THAT PROVIDE ORGANISM-SPECIFIC AND CROSS-GROUP PROTECTION

<130> 130189-00420

<140>
<141>

<150> 16/737,546
<151> 2020-01-08

<160> 28    

<170> PatentIn version 3.5

<210> 1

<400> 1
000


<210> 2

<400> 2
000


<210> 3
<211> 26
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 3
gaagaggcaa tgcaaaatag aataca                                            26


<210> 4
<211> 23
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 4
cccgaagcta aaccaragta tca                                               23


<210> 5
<211> 27
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      probe

<400> 5
ccagtcaaac taagcagygg ctacaaa                                           27


<210> 6
<211> 21
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 6
gaccgatcct gtcacctctg a                                                 21


<210> 7
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 7
agggcattct ggacaaagcg tcta                                              24


<210> 8
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      probe

<400> 8
tgcagtcctc gctcactggg cacg                                              24


<210> 9
<211> 21
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 9
caatgtgtcc gtcgtggatc t                                                 21


<210> 10
<211> 22
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 10
gtcctcagtg tagcccaaga tg                                                22


<210> 11
<211> 23
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      probe

<400> 11
cgtgccgcct ggagaaacct gcc                                               23


<210> 12
<211> 9
<212> PRT
<213> Influenza A virus

<400> 12
Gly Ile Leu Gly Phe Val Phe Thr Leu 
1               5                   


<210> 13
<211> 8
<212> PRT
<213> Influenza A virus

<400> 13
Met Gly Leu Ile Tyr Asn Arg Met 
1               5               


<210> 14
<211> 9
<212> PRT
<213> Influenza A virus

<400> 14
Leu Tyr Arg Lys Leu Lys Arg Glu Ile 
1               5                   


<210> 15
<211> 23
<212> PRT
<213> Influenza A virus

<400> 15
Ser Leu Leu Thr Glu Val Glu Thr Pro Ile Arg Asn Glu Trp Gly Cys 
1               5                   10                  15      


Arg Cys Asn Asp Ser Ser Asp 
            20              


<210> 16
<211> 10
<212> PRT
<213> Influenza A virus

<400> 16
Ala Thr Tyr Gln Arg Thr Arg Ala Leu Val 
1               5                   10  


<210> 17
<211> 9
<212> PRT
<213> Influenza A virus

<400> 17
Ala Ser Asn Glu Asn Met Asp Thr Met 
1               5                   


<210> 18
<211> 9
<212> PRT
<213> Influenza A virus

<400> 18
Ser Arg Tyr Trp Ala Ile Arg Thr Arg 
1               5                   


<210> 19
<211> 9
<212> PRT
<213> Influenza A virus

<400> 19
Ser Ser Tyr Arg Arg Val Pro Gly Ile 
1               5                   


<210> 20
<211> 10
<212> PRT
<213> Influenza A virus

<400> 20
Val Ser Gly Val Asn Glu Ser Ala Asp Met 
1               5                   10  


<210> 21
<211> 9
<212> PRT
<213> Influenza A virus

<400> 21
Asp Gly Gly Pro Asn Leu Tyr Asn Ile 
1               5                   


<210> 22
<211> 9
<212> PRT
<213> Influenza A virus

<400> 22
Ile Ser Pro Leu Met Val Ala Tyr Met 
1               5                   


<210> 23
<211> 9
<212> PRT
<213> Influenza A virus

<400> 23
Val Leu Thr Gly Asn Leu Gln Thr Leu 
1               5                   


<210> 24
<211> 10
<212> PRT
<213> Influenza A virus

<400> 24
Ser Val Leu Val Asn Thr Tyr Gln Trp Ile 
1               5                   10  


<210> 25
<211> 10
<212> PRT
<213> Influenza A virus

<400> 25
Ser His Leu Arg Asn Asp Thr Asp Val Val 
1               5                   10  


<210> 26
<211> 9
<212> PRT
<213> Influenza A virus

<400> 26
Thr Asp Val Val Asn Phe Val Ser Met 
1               5                   


<210> 27
<211> 9
<212> PRT
<213> Influenza A virus

<400> 27
Val Glu Glu Gly Ser Ile Gly Lys Val 
1               5                   


<210> 28
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 28
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser 
1               5                   10                  15  


